Research Article

Two-Stage Joint Model for Multivariate Longitudinal and Multistate Processes, with Application to Renal Transplantation Data

Table 3

The results of the multistate models (Stage 2) for different association structures between longitudinal and multistate processes.

Association structure: true slope of longitudinal biomarkers
Transition 1 to 2Transition 2 to 3Transition 1 to 3
VariablesCoef (SE)HR (95% CI)-valueCoef (SE)HR (95% CI)-valueCoef (SE)HR (95% CI)-value

DRG0.12 (0.11)1.13 (0.91, 1.40)0.2580.22 (0.12)1.24 (0.98, 1.57)0.069−0.32 (0.35)0.73 (0.98, 1.57)0.370
Recipient age−0.01 (0.01)0.99 (0.97, 1.01)0.3170.04 (0.02)1.04 (1.00, 1.08)0.0450.005 (0.01)1.00 (0.98, 1.03)0.709
Creatinine0.22 (0.12)1.25 (0.98, 1.58)0.0670.49 (0.26)1.63 (0.98, 2.72)0.0591.05 (0.54)2.87 (0.99, 8.31)0.052
Hemoglobin−0.15 (0.08)0.86 (0.74, 1.01)0.061−0.17 (0.09)0.84 (0.71, 1.01)0.0580.36 (0.26)1.44 (0.86,2.42)0.168
BUN0.02 (0.01)1.02 (1.00, 1.04)0.045−0.01 (0.01)0.99 (0.98, 1.00)0.1430.01 (0.01)1.01 (0.99, 1.03)0.176
−2(loglikelihood)5714.38

Association structure: true value of longitudinal biomarkers
Transition 1 to 2Transition 2 to 3Transition 1 to 3
VariablesCoef (SE)HR (95% CI)-valueCoef (SE)HR (95% CI)-valueCoef (SE)HR (95% CI)-value

DRG0.02 (0.11)1.02 (0.83, 1.27)0.837−0.07 (0.12)0.93 (0.74, 1.18)0.554−0.17 (0.37)0.85 (0.41, 0.74)0.651
Recipient age−0.02 (0.02)0.98 (0.94, 1.02)0.3170.12 (0.05)1.13 (1.02,1.24)0.0160.01 (0.02)1.01 (0.97, 1.05)0.617
Creatinine0.45 (0.22)1.57 (1.02, 2.41)0.0400.13 (0.26)1.14 (0.68, 1.89)0.6170.67 (0.35)1.95 (0.98, 3.88)0.055
Hemoglobin−0.68 (0.05)0.51 (0.46, 0.56)<0.001−0.44 (0.22)0.64 (0.42, 0.99)0.045−0.06 (0.07)0.94 (0.82, 1.09)0.454
BUN0.03 (0.01)1.03 (1.01, 1.05)0.0030.01 (0.01)1.01 (0.99, 1.03)0.317−0.01 (0.01)0.99 (0.97, 1.01)0.381
−2(loglikelihood)5061.89

Association structure: both true slope and true value of longitudinal biomarkers
Transition 1 to 2Transition 2 to 3Transition 1 to 3
VariablesCoef (SE)HR (95% CI)-valueCoef (SE)HR (95% CI)-valueCoef (SE)HR (95% CI)-value

DRG−0.01 (0.11)0.99 (0.80, 1.23)0.927−0.03 (0.12)0.97 (0.77, 1.23)0.807−0.13 (0.37)0.88 (0.42, 1.82)0.728
Recipient age−0.015 (0.01)0.98 (0.96, 1.00)0.1340.01 (0.005)1.01 (1.00, 1.02)0.0240.01 (0.01)1.01 (0.98, 1.04)0.374
Creatinine1.31 (0.38)3.71 (1.76, 7.83)<0.0010.08 (0.32)1.08 (0.59, 2.03)0.8021.44 (0.62)4.22 (1.25, 14.29)0.020
−1.85 (0.41)0.16 (0.07, 0.35)<0.0010.54 (0.36)1.72 (0.85, 3.47)0.1341.13 (0.59)3.09 (0.97, 9.83)0.055
Hemoglobin−0.83 (0.06)0.44 (0.39, 0.49)<0.001−0.47 (0.07)0.62 (0.54, 0.72)<0.0010.06 (0.09)1.06 (0.89, 1.27)0.484
−0.11 (0.07)0.89 (0.78, 1.01)0.083−0.05 (0.08)0.95 (0.81, 1.12)0.5710.43 (0.21)1.54 (1.03, 2.31)0.035
BUN0.01 (0.01)1.01 (0.99,1.03)0.0740.01 (0.01)1.01 (0.99, 1.02)0.480−0.01 (0.01)0.98 (0.97, 1.00)0.120
0.05 (0.01)1.05 (1.04, 1.06)<0.0010.03 (0.02)1.03 (0.99, 1.07)0.1340.05 (0.03)1.05 (0.99, 1.11)0.095
−2(loglikelihood)4981.07

Association structure: the area under the biomarkers’ trajectories
Transition 1 to 2Transition 2 to 3Transition 1 to 3
VariablesCoef (SE)HR (95% CI)-valueCoef (SE)HR (95% CI)-valueCoef (SE)HR (95% CI)-value

DRG0.04 (0.11)0.96 (0.78, 1.19)0.7420.26 (0.12)1.30 (1.03, 1.64)0.200−0.47 (0.37)0.62 (0.30, 1.28)0.203
Recipient age−0.05 (0.02)0.95 (0.91, 0.99)0.0130.13 (0.05)1.14 (1.03, 1.26)0.0090.01 (0.01)1.01 (0.98, 1.04)0.425
Creatinine0.09 (0.04)1.10 (1.01, 1.18)0.0240.07 (0.04)1.07 (0.99, 1.16)0.0800.15 (0.08)1.16 (0.99, 1.36)0.061
Hemoglobin−0.10 (0.04)0.90 (0.84, 0.98)0.012−0.09 (0.04)0.91 (0.84, 0.99)0.023−0.02 (0.01)0.98 (0.97, 1.00)0.134
BUN0.12 (0.05)1.13 (1.02, 1.24)0.0160.02 (0.01)1.02 (1.00, 1.04)0.069−0.001 (0.001)1.00 (0.99, 1.01)0.133
−2(loglikelihood)4013.425